Related references
Note: Only part of the references are listed.Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
Leslie M. Shaw et al.
ACTA NEUROPATHOLOGICA (2011)
Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-beta(38/40/42) in Frontotemporal Dementias and Primary Progressive Aphasias
Mirko Bibl et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Ezra Mulugeta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
Josef Marksteiner et al.
NEUROBIOLOGY OF AGING (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid
Erik Portelius et al.
EXPERIMENTAL NEUROLOGY (2010)
Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
P. Lewczuk et al.
EXPERIMENTAL NEUROLOGY (2010)
ERK2 is Increased in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients
Petra Steinacker et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
T. T. Seppala et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
P. Lewczuk et al.
MOLECULAR PSYCHIATRY (2010)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Rapid Progression from Mild Cognitive Impairment to Alzheimer's Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype
Elin S. Blom et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form
Hans-Wolfgang Klafki et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Petra Steinacker et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer's disease
Volker Welge et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Identification of Novel APP/A beta Isoforms in Human Cerebrospinal Fluid
Erik Portelius et al.
NEURODEGENERATIVE DISEASES (2009)
Association of plasma amyloid β with risk of dementia The prospective Three-City Study
J. -C. Lambert et al.
NEUROLOGY (2009)
TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Petra Steinacker et al.
ARCHIVES OF NEUROLOGY (2008)
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2008)
Cerebrospinal fluid neurochemical phenotypes in vascular dementias: Original data and mini-review
Mirko Bibl et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics
Mirko Bibl et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Biomarkers for early diagnosis of Alzheimer disease:: 'ALZheimer ASsociated gene' -: a new blood biomarker?
Kurt A. Jellinger et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI:: A multicenter study
Piotr Lewczuk et al.
NEUROBIOLOGY OF AGING (2008)
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides
K. Hoglund et al.
NEURODEGENERATIVE DISEASES (2008)
CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction
Mirko Bibl et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
K. Iqbal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Blood-based neurochemical diagnosis of vascular dementia: A pilot study
Mirko Bibl et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias
M. Bibl et al.
MOLECULAR PSYCHIATRY (2007)
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration
Y. A. L. Pijnenburg et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho-Tau in patients with low- and high-CSF Aβ40 load
Jens Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations
M. Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid β42 and Tau proteins
Thierry S. M. Reijn et al.
CLINICAL CHEMISTRY (2007)
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies
Brit Mollenhauer et al.
NEURODEGENERATIVE DISEASES (2007)
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain
A. Guentert et al.
NEUROSCIENCE (2006)
Therapeutic approaches to Alzheimer's disease
Hans-Wolfgang Klafki et al.
BRAIN (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Plasma Aβ1-40 and Aβ1-42 and the risk of dementia:: a prospective case-cohort study
Marieke van Oijen et al.
LANCET NEUROLOGY (2006)
Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: Genetic and bioinformatic assessment
Cezary Zekanowski et al.
EXPERIMENTAL NEUROLOGY (2006)
Cerebrospinal fluid amyloidβ42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
Danielle de Jong et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Circulating biomarkers of cognitive decline and dementia
V Solfrizzi et al.
CLINICA CHIMICA ACTA (2006)
Amino-truncated β-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment
H Vanderstichele et al.
CLINICAL CHEMISTRY (2005)
CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment
SK Herukka et al.
NEUROLOGY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Tau protein, A beta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
B Mollenhauer et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
A novel presenilin 1 mutation associated with Pick's disease but not β-amyloid plaques
B Dermaut et al.
ANNALS OF NEUROLOGY (2004)
Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides
M Bibl et al.
ELECTROPHORESIS (2004)
Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases
P Steinacker et al.
NEUROSCIENCE LETTERS (2004)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study
H Hampel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to β-amyloid peptide42
A Maddalena et al.
ARCHIVES OF NEUROLOGY (2003)
Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease
E Gómez-Tortosa et al.
ARCHIVES OF NEUROLOGY (2003)
β-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
J Wiltfang et al.
ANNALS OF NEUROLOGY (2003)
Tau and Aβ42 protein in CSF of patients with frontotemporal degeneration
M Riemenschneider et al.
NEUROLOGY (2002)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay
YY Hu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease
N Itoh et al.
ANNALS OF NEUROLOGY (2001)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies
L Parnetti et al.
NEUROLOGICAL SCIENCES (2001)
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse et al.
NEUROSCIENCE LETTERS (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
R Kohnken et al.
NEUROSCIENCE LETTERS (2000)
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
M Sjögren et al.
NEUROLOGY (2000)
Cerebrospinal beta-amyloid (1-42) in early Alzheimer's disease:: association with apolipoprotein E genotype and cognitive decline
M Riemenschneider et al.
NEUROSCIENCE LETTERS (2000)
Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies
K Kanemaru et al.
NEUROLOGY (2000)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid:: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen et al.
NEUROSCIENCE LETTERS (2000)
Amyloid Aβ40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia
C Andersen et al.
NEUROREPORT (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Genetic and biochemical markers for Alzheimer's disease: recent developments
C Mulder et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2000)
Share Paper
